Old Web
English
Sign In
Acemap
>
authorDetail
>
Dan Prelusky
Dan Prelusky
Merck & Co.
Chemistry
Biochemistry
Bioavailability
Pyrazine
Aurora kinase
4
Papers
97
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification
2010
Journal of Pharmaceutical and Biomedical Analysis
Tongtong Liu
Lee Jah Chang
Annette S. Uss
Inhou Chu
Richard A. Morrison
Lydia Wang
Dan Prelusky
Kuo-Chi Cheng
Cheng Li
Show All
Source
Cite
Save
Citations (14)
Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration.
2010
European Journal of Pharmacology
Richard W. Chapman
Aileen House
Jennifer Richard
Dan Prelusky
James Lamca
Peng Wang
Dan Lundell
Ping Wu
Pauline C. Ting
Joe F. Lee
Robert Aslanian
Jonathan Phillips
Show All
Source
Cite
Save
Citations (24)
Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors.
2010
Bioorganic & Medicinal Chemistry Letters
David B. Belanger
Michael Williams
Patrick J. Curran
Amit K. Mandal
Zhaoyang Meng
Matthew P. Rainka
Tao Yu
Neng-Yang Shih
M. Arshad Siddiqui
Ming Liu
Seema Tevar
Suining Lee
Lianzhu Liang
Kimberly Gray
Bohdan Yaremko
Jennifer Jones
Elizabeth B. Smith
Dan Prelusky
Andrea D. Basso
Show All
Source
Cite
Save
Citations (15)
1